Skip to main content
Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
293.50
+2.13 (0.73%)
Jun 29, 2026, 10:29 AM EDT - Market open

Alnylam Pharmaceuticals Revenue by Segment
Period Ending Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Amvuttra
2.89B 2.31B 1.77B 1.35B 1.09B 970.41M 859.20M 749.30M
Amvuttra Growth
166.66% 138.44% 106.44% 79.78% 66.62% 73.94% 90.43% 128.65%
Collaboration
536.26M 553.37M 619.37M 325.03M 490.83M 510.15M 479.60M 849.70M
Collaboration Growth
9.25% 8.47% 29.14% -61.75% -21.87% -6.60% -11.25% 497.54%
Givlaari
315.91M 308.49M 286.34M 283.46M 264.71M 255.85M 250.50M 233.60M
Givlaari Growth
19.34% 20.58% 14.31% 21.35% 15.39% 16.72% 21.01% 17.62%
Oxlumo
200.67M 191.44M 185.36M 172.73M 166.46M 166.97M 156.10M 144.60M
Oxlumo Growth
20.55% 14.65% 18.75% 19.46% 29.85% 52.07% 54.71% 63.21%
Royalty
196.53M 174.02M 148.04M 125.23M 107.65M 91.79M 73.40M 59.90M
Royalty Growth
82.56% 89.59% 101.68% 109.07% 140.83% 126.08% 179.09% 213.61%
Onpattro
143.78M 172.79M 197.21M 208.43M 233.09M 252.80M 275.70M 307.00M
Onpattro Growth
-38.32% -31.65% -28.47% -32.11% -27.45% -28.71% -30.69% -33.43%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.